BriefCase vs Coding Intelligence (OpenEvidence Visits)

OpenEvidence Visits offers a highly intuitive user experience with features like real-time transcription, automatic note generation, and integrated intelligence for editing and literature searches. Its mobile and web access, along with voice mode interaction, further enhance its usability for physicians at the point of care. Aidoc's BriefCase, while offering mobile access and seamless integration with existing hospital systems, is primarily focused on communication and collaboration around imaging findings, which suggests a more specialized workflow rather than a broad, intuitive clinical assistant.

Aidoc's BriefCase is an FDA-cleared solution that uses AI to detect critical medical imaging findings and streamline communication among care teams, leading to faster time-to-treatment and reduced length of stay in several studies. OpenEvidence Visits provides evidence-based answers and assists with clinical documentation and coding, but some studies indicate its impact on actual clinical decision-making can be modest, often reinforcing existing decisions rather than changing them.

OpenEvidence Visits is free for NPI-verified physicians, making it highly accessible and offering significant value at no direct cost to individual clinicians. Its funding model relies on pharmaceutical advertising, which is transparently disclosed. Aidoc's BriefCase operates on an enterprise pricing model, with costs starting around $50,000 per site per year, which can be a barrier for smaller institutions.

Aidoc's BriefCase is designed for large hospitals and health systems, with robust features like seamless integration with PACS, RIS, and EHR systems, comprehensive audit trails, and multiple FDA clearances across various pathologies. It also boasts over 500 hospital customers globally and SOC2, HIPAA, and GDPR compliance. OpenEvidence, while widely adopted by individual physicians, has a free, ad-supported model for individuals and its enterprise expansion is still developing, with some limitations for broader business use.

Both tools demonstrate significant innovation in their respective domains. Aidoc's BriefCase leverages AI for critical imaging finding detection and care team communication, with a focus on a comprehensive AI operating system (aiOS) and a foundation model approach for multiple pathologies. OpenEvidence Visits innovates by integrating real-time evidence, AI-powered note generation, and coding suggestions directly into the clinical encounter, aiming to be a comprehensive AI copilot for doctors.

The provided information does not offer specific details on the depth or accessibility of support and documentation for either Aidoc's BriefCase or OpenEvidence Visits. While both are established companies in the healthcare AI space, without explicit information on their support channels, user guides, or developer documentation, it is not possible to definitively pick a winner in this dimension.